EXACT SCIENCES CORPO

EXAS

Delayed Nasdaq - 04:00 2022-11-28 pm EST
41.50 USD	-2.70%

Turn to zoom

Prev.	41.50000000
Open	42.23000000
High	43.23000000
Low	41.08000000
Volume	1 250 385

11/15	Transcript : Exact Sciences Corporation Presents at 13th Annual Jefferies...
11/14	Piper Sandler Boosts Price Target for Exact Sciences to $50 From $40,...
11/08	Transcript : Exact Sciences Corporation Presents at Credit Suisse 31st...
11/07	Raymond James Adjusts Price Target on Exact Sciences to $60 From $70,...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bearish
Resistance	46,3	51,2	48,8
Spread/Res.	-10%	-19%	-15%
Spread/Supp.	9,5%	37%	37%
Support	37,9	30,4	30,4

Sales 2022	2 035 M - -
Net income 2022	-650 M - -
Net Debt 2022	1 750 M - -
P/E ratio 2022	-11,4x
Yield 2022	-

Capitalization	7 374 M 7 374 M -
EV / Sales 2022	4,48x
EV / Sales 2023	3,99x
Nbr of Employees	6 460
Free-Float	99,1%

Exact Sciences Corporation is a global cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection. It offers laboratory testing services from its Cologuard colorectal cancer screening test, Oncotype DX cancer diagnostic tests and services, and COVID-19...

Sector :

Bio Diagnostics & Testing

Calendar :

2022-11-29 Presentation

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	BUY
Number of Analysts	18
Last Close Price	41,50 $
Average target price	59,12 $
Spread / Average Target	42,5%